Recent progress in artificial intelligence and machine learning for novel diabetes mellitus medications development
Author:
Affiliation:
1. School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, P. R. China
Funder
the Science Foundation of Heilongjiang Administration of Traditional Chinese Medicine
Publisher
Informa UK Limited
Link
https://www.tandfonline.com/doi/pdf/10.1080/03007995.2024.2387187
Reference99 articles.
1. Emerging technologies and their impact on regulatory science
2. Role of innovation in pharmaceutical regulation: A proposal for principles to evaluate EU General Pharmaceutical Legislation from the innovator perspective
3. Prevalence, Progression, and Modifiable Risk Factors for Diabetic Retinopathy in Youth and Young Adults With Youth-Onset Type 1 and Type 2 Diabetes: The SEARCH for Diabetes in Youth Study
4. An Insight into the Development of Potential Antidiabetic Agents along with their Therapeutic Targets
5. Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3